Swissmedic Annual Report 2021

6
Die von Swissmedic durchgeführten Inspektionen (79)
verteilen sich auf folgende Bereiche
44
44% Pharma
MEDICINAL PRODUCTS – Market Surveillance Other
2% For-Cause-Inspektionen
product group
(notifications from abroad, theft abroad, etc.)
14% Blutspendewesen
Out-of-Stock
40% Transplantatprodukte
Total number of out-of-stock applications
Number of COVID-19-related
out-of-stock applications
2021 2020
Measures against illegal medicinal products
2020 2021
37 62
12 34
Seite 45 Arzneimittel
Produktegruppe Marktüberwachung
Proceedings connected with illegal imports
Illegal distribution of medicinal products
51
77
Counterfeit medicinal products
111
6,733
Cases evaluated and forwarded to the
responsible cantonal agencies
57
65
8,790
165
Enquiries
Control of advertising
m
35
82
87
88
Swissmedic controls and monitors the
advertising of medicinal products and is
responsible for the risk-based processing of
infringements of advertising rules involving
authorised medicinal products that are reported
to it or which it identifies by screening advertising
destined for the public. This includes checking
printed, TV and other electronic advertising
destined for the public with the specific aim of
identifying and banning misleading advertising
that could induce people to take excessive
quantities of medicinal products or lead them to
believe that medicinal products are safer than they
are. Swissmedic responds to infringements that
jeopardise patient safety by initiating relevant
procedures to enforce corrective actions. Publications,
information sheets and presentations are
used to inform stakeholders of the current
requirements governing medicinal product
advertising.
Activities:
A total of 47 (previous year: 24) cases were dealt with
as part of post-publication advertising inspection activities
during 2021. Administrative proceedings had to be
opened in 37 cases for the purpose of restoring legal
compliance. 31 cases involved print advertising, while
six involved advertising on electronic media, including
TV commercials. In the remaining ten cases, Swissmedic
found no infringements of advertising rules or was not
responsible for enforcement and therefore forwarded
the reports to the relevant agency.
Enquiries
35
82
Seven applications for advertising permits for laxatives
were received.
s
20
Other
(notifications from abroad, theft abroad, etc.)
87
88
Measures against illegal medicinal
products
m
Swissmedic sensitises the public to the risks
associated with using illegal medicinal
products. It maintains dialogue with other
authorities and promotes effective national and
international networking. Swissmedic receives
reports of counterfeit medicinal products, illegal
activities and illegal distribution, examines them
and initiates corrective action where necessary.
Swissmedic works closely with the customs
authorities to control medicine imports and
orders the destruction of illegal packages.